A study published in the European Heart Journal on Feb. 18 suggests healthcare expenditures in Europe would skyrocket if local systems adopted experts’ latest guidelines for cholesterol-lowering treatment.
People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.
A two-year collaboration between the North Carolina chapter of the American College of Cardiology and North Carolina Association of Free and Charitable Clinics was successful in providing thousands of underserved heart patients with free lipid-lowering therapy and clopidogrel.
More than 15% of adults in all U.S. states and territories were physically inactive between 2015 and 2018, according to recent data from the CDC, with estimates ranging from 17.3% to 47.7% between regions.
A cross-structural analysis published in Mayo Clinic Proceedings this January independently links diabetes to the development of heart failure, suggesting diabetic cardiomyopathy is a real—and growing—issue in the U.S.